BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20008829)

  • 21. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project.
    Rothenbacher D; Rehm M; Iacoviello L; Costanzo S; Tunstall-Pedoe H; Belch JJF; Söderberg S; Hultdin J; Salomaa V; Jousilahti P; Linneberg A; Sans S; Padró T; Thorand B; Meisinger C; Kee F; McKnight AJ; Palosaari T; Kuulasmaa K; Waldeyer C; Zeller T; Blankenberg S; Koenig W;
    BMC Med; 2020 Nov; 18(1):300. PubMed ID: 33161898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin C-based estimated GFR and albuminuria are independently associated with all-cause and CVD mortality in Korean population: The Dong-gu Study.
    Kim HY; Kweon SS; Lee YH; Ryu SY; Nam HS; Shin MH; Park KS; Choi SW
    Maturitas; 2021 Jan; 143():178-183. PubMed ID: 33308626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of age and measure of eGFR on the association between renal function and cardiovascular events.
    van der Velde M; Bakker SJ; de Jong PE; Gansevoort RT
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2053-9. PubMed ID: 20705964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.
    Upadhyay A; Larson MG; Guo CY; Vasan RS; Lipinska I; O'Donnell CJ; Kathiresan S; Meigs JB; Keaney JF; Rong J; Benjamin EJ; Fox CS
    Nephrol Dial Transplant; 2011 Mar; 26(3):920-6. PubMed ID: 20682604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes.
    Foster MC; Hwang SJ; Larson MG; Parikh NI; Meigs JB; Vasan RS; Wang TJ; Levy D; Fox CS
    Arch Intern Med; 2007 Jul; 167(13):1386-92. PubMed ID: 17620532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.
    Vlek AL; van der Graaf Y; Spiering W; Algra A; Visseren FL;
    J Intern Med; 2008 Oct; 264(4):351-60. PubMed ID: 18522685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
    Mok Y; Ballew SH; Sang Y; Grams ME; Coresh J; Evans M; Barany P; Ärnlöv J; Carrero JJ; Matsushita K
    J Am Heart Assoc; 2019 Apr; 8(8):e010546. PubMed ID: 30947615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
    Warnock DG; Muntner P; McCullough PA; Zhang X; McClure LA; Zakai N; Cushman M; Newsome BB; Kewalramani R; Steffes MW; Howard G; McClellan WM;
    Am J Kidney Dis; 2010 Nov; 56(5):861-71. PubMed ID: 20692752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
    van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey A; de Jong P; Gansevoort RT; ; van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey AS; de Jong PE; Gansevoort RT; Levey A; El-Nahas M; Eckardt KU; Kasiske BL; Ninomiya T; Chalmers J; Macmahon S; Tonelli M; Hemmelgarn B; Sacks F; Curhan G; Collins AJ; Li S; Chen SC; Hawaii Cohort KP; Lee BJ; Ishani A; Neaton J; Svendsen K; Mann JF; Yusuf S; Teo KK; Gao P; Nelson RG; Knowler WC; Bilo HJ; Joosten H; Kleefstra N; Groenier KH; Auguste P; Veldhuis K; Wang Y; Camarata L; Thomas B; Manley T
    Kidney Int; 2011 Jun; 79(12):1341-52. PubMed ID: 21307840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
    Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
    Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystatin C as a risk factor for outcomes in chronic kidney disease.
    Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
    Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults.
    Werner K; Christensson A; Legrand H; Pihlsgård M; Sterner G; Elmståhl S
    Aging Clin Exp Res; 2019 Oct; 31(10):1461-1469. PubMed ID: 30560432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study.
    Barr EL; Reutens A; Magliano DJ; Wolfe R; Lu ZX; Sikaris KA; Tanamas SK; Atkins R; Chadban S; Shaw JE; Polkinghorne KR
    Nephrology (Carlton); 2017 Mar; 22(3):243-250. PubMed ID: 26938304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of creatinine and cystatin C-based eGFR equations in Chinese older adults with chronic kidney disease.
    Guan C; Liang M; Liu R; Qin S; He F; Li J; Zhu X; Dai H; Fu J
    Int Urol Nephrol; 2018 Dec; 50(12):2229-2238. PubMed ID: 29948865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study.
    Park M; Maristany D; Huang D; Shlipak MG; Whooley M
    Atherosclerosis; 2017 Aug; 263():68-73. PubMed ID: 28601698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.